Clinicopathological Characteristics of Light and Heavy Chain Deposition Disease: A Case Series

Am J Kidney Dis. 2024 Oct;84(4):447-456.e1. doi: 10.1053/j.ajkd.2024.03.021. Epub 2024 May 14.

Abstract

Rationale & objective: Light and heavy chain deposition disease (LHCDD) is a rare form of monoclonal immunoglobulin (Ig) deposition disease, and limited clinical data are available characterizing this condition. Here we describe the clinicopathological characteristics and outcomes of LHCDD.

Study design: Case series.

Setting & participants: 13 patients with biopsy-proven LHCDD diagnosed between January 2008 and December 2022 at one of 2 Chinese medical centers.

Findings: Among the 13 patients described, 6 were men and 7 were women, with a mean age of 52.6±8.0 years. Patients presented with hypertension (76.9%), anemia (84.6%), increased serum creatinine concentrations (84.6%; median, 1.7mg/dL), proteinuria (100%; average urine protein, 3.0g/24h), nephrotic syndrome (30.8%), and microscopic hematuria (76.9%). Serum immunofixation electrophoresis showed monoclonal Ig for 11 patients (84.6%). Serum free light chain ratios were abnormal in 11 patients (84.6%), and heavy/light chain ratios were abnormal in 9 of 10 patients (90%) with available data. Five patients were diagnosed with multiple myeloma. A histological diagnosis of nodular mesangial sclerosis was made in 10 patients (76.9%). Immunofluorescence demonstrated deposits of IgG subclass in 7 patients (γ-κ, n=4; γ-λ, n=3) and IgA in 5 patients (α-κ, n=2; α-λ, n=3). Six patients underwent IgG subclass staining (γ1, n=3; γ2, n=2; γ3, n=1). The deposits of IgD-κ were confirmed by mass spectrometry in 1 patient. Among 12 patients for whom data were available during a median of 26.5 months, 11 received chemotherapy and 1 received conservative treatment. One patient died, and disease progressed to kidney failure in 3 (25%). Among the 9 patients evaluable for hematological and kidney disease progression, 5 (56%) had a hematologic response and 1 (11%) exhibited improvement in kidney disease.

Limitations: Retrospective descriptive study, limited number of patients, urine protein electrophoresis or immunofixation electrophoresis test results missing for most patients.

Conclusions: In this case series of LHCDD, light and heavy chain deposition in kidney tissues were most frequent with monoclonal IgG1-κ. Among patients with evaluable data, more than half had a hematologic response, but a kidney response was uncommon.

Keywords: Light and heavy chain deposition disease; case series; heavy/light chain assay; monoclonal gammopathy of renal significance; monoclonal immunoglobulin deposition disease; outcome.

MeSH terms

  • Adult
  • Aged
  • Female
  • Heavy Chain Disease / diagnosis
  • Heavy Chain Disease / pathology
  • Humans
  • Immunoglobulin Heavy Chains*
  • Immunoglobulin Light Chains* / analysis
  • Immunoglobulin Light Chains* / urine
  • Male
  • Middle Aged
  • Paraproteinemias / complications
  • Paraproteinemias / diagnosis
  • Paraproteinemias / pathology
  • Retrospective Studies

Substances

  • Immunoglobulin Heavy Chains
  • Immunoglobulin Light Chains